Search Results - "HOM, Glory"

Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation by ANTONESCU, Cristina R, BESMER, Peter, BRENNAN, Murray F, MAKI, Robert G, DEMATTEO, Ronald P, TIANHUA GUO, ARKUN, Knarik, HORN, Glory, KORYOTOWSKI, Beata, LEVERSHA, Margaret A, JEFFREY, Philip D, DESANTIS, Diann, SINGER, Samuel

“…Most gastrointestinal stromal tumors (GIST) have an activating mutation in either KIT or PDGFRA . Imatinib is a selective tyrosine kinase inhibitor and…”
Get full text

Sorafenib Inhibits the Imatinib-Resistant KITT670I Gatekeeper Mutation in Gastrointestinal Stromal Tumor by Guo, Tianhua, Agaram, Narasimhan P, Wong, Grace C, Hom, Glory, D'Adamo, David, Maki, Robert G, Schwartz, Gary K, Veach, Darren, Clarkson, Bayard D, Singer, Samuel, DeMatteo, Ronald P, Besmer, Peter, Antonescu, Cristina R

“…Purpose: Resistance is commonly acquired in patients with metastatic gastrointestinal stromal tumor who are treated with imatinib mesylate, often due to the…”
Get full text

Sorafenib inhibits the imatinib-resistant KITT6701 gatekeeper mutation in gastrointestinal stromal tumor by TIANHUA GUO, AGARAM, Narasimhan P, DEMATTEO, Ronald P, BESMER, Peter, ANTONESCUL, Cristina R, WONG, Grace C, HOM, Glory, D'ADAMO, David, MAKI, Robert G, SCHWARTZ, Gary K, VEACH, Darren, CLARKSON, Bayard D, SINGER, Samuel

Get full text

Sorafenib Inhibits the Imatinib-Resistant KIT T670I Gatekeeper Mutation in Gastrointestinal Stromal Tumor by Guo, Tianhua, Agaram, Narasimhan P., Wong, Grace C., Hom, Glory, D'Adamo, David, Maki, Robert G., Schwartz, Gary K., Veach, Darren, Clarkson, Bayard D., Singer, Samuel, DeMatteo, Ronald P., Besmer, Peter, Antonescu, Cristina R.

“…Purpose: Resistance is commonly acquired in patients with metastatic gastrointestinal stromal tumor who are treated with imatinib mesylate, often due to the…”
Get full text